LOADING
Comparing Exxon Mobil Corporation (XOM) and Johnson & Johnson (JNJ) across the Energy and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | XOM | JNJ |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $601.4B | $611.1B |
| P/E Ratio | 24.3 | 29.4 |
| Forward P/E | 12.8 | 22.3 |
| PEG Ratio | 1.20 | 4.95 |
| EPS | $5.96 | $8.64 |
| Revenue Growth (YoY) | 2.6% | 9.9% |
| Profit Margin | 7.8% | 21.8% |
| Return on Equity | 9.9% | 26.4% |
| Dividend Yield | 2.80% | 2.02% |
| Beta | 0.16 | 0.23 |
| 52-Week High | $175.22 | $269.43 |
| 52-Week Low | $102.27 | $158.33 |
| Volume | -- | -- |
Johnson & Johnson is the larger company by market capitalization. Exxon Mobil Corporation trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Exxon Mobil Corporation offers a higher dividend yield for income investors. Johnson & Johnson has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.